• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

AVX:AU

0.0130 AUD 0.0010 8.33%

As of 01:17:08 ET on 07/11/2014.

Snapshot for Avexa Ltd (AVX)

Open: 0.0120 Day's Range: 0.0110 - 0.0130 Volume: 768,850
Previous Close: 0.0120 52wk Range: 0.0110 - 0.0260 1-Yr Rtn: -13.33%

Stock Chart for AVX

No chart data available.
  • AVX:AU 0.0130
  • 1D
  • 1M
  • 1Y
0.0120
Interactive AVX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AVX

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0031
Est. EPS (AUD) (06/2014) -
Est. PEG Ratio -
Market Cap (M AUD) 12.03
Shares Outstanding (M) 925.65
30 Day Average Volume 472,411
Price/Book (mrq) 0.9208
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AVX

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for AVX

Avexa Limited is a pharmaceutical company focused on the research and development of anti-infective drugs for such diseases as HIV, Hepatitis B, and vancomycin resistant bacterial infections.

Jonathan A V CoatesChief Scientific Ofcr/Interim CEOLee MitchellSecretary
M KlapakisController
More Company Profile & Key Executives for AVX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil